AtaiBeckley (ATAI) Interest & Investment Income (2020 - 2026)
AtaiBeckley (ATAI) recorded quarterly Interest & Investment Income of $78000.0 in Q1 2026, down 58.06% quarter-over-quarter from $186000.0 in Q1 2025, and down 58.06% on a YoY basis from $186000.0 in Q1 2025.
AtaiBeckley (ATAI) Interest & Investment Income (2020 - 2026) Analysis & Trends
AtaiBeckley has disclosed Interest & Investment Income across 6 years of filings, most recently posting $504000.0 for Q3 2025.
- Interest & Investment Income for Q3 2025 came in at $504000.0, up 215.0% year-over-year; the trailing twelve-month figure through Sep 2025 was $1.1 million (down 8.86% YoY), and the FY2024 annual result was $778000.0, down 57.88% from the prior year.
- Interest & Investment Income was $78000.0 for Q1 2026 at AtaiBeckley, down from $186000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $186000.0 in Q1 2025 to a low of $78000.0 in Q1 2026.
- The 5-year median for Interest & Investment Income is $186000.0 (2025), against an average of $227052.6.
- Across the five-year window, Interest & Investment Income soared 1712.5% in 2022 and tumbled 73.86% in 2024, its largest moves.
- AtaiBeckley's Interest & Investment Income stood at $125000.0 in 2021, then surged by 49.6% to $187000.0 in 2022, then jumped by 250.8% to $656000.0 in 2023, then slumped by 70.58% to $193000.0 in 2024, then surged by 161.14% to $504000.0 in 2025.
- The last three Interest & Investment Income figures came in at $504000.0 (Q3 2025), $248000.0 (Q2 2025), and $186000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78,000.00 |
| Sep 30, 2025 | 504,000.00 |
| Jun 30, 2025 | 248,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Sep 30, 2024 | 160,000.00 |
| Jun 30, 2024 | 118,000.00 |
| Mar 31, 2024 | 307,000.00 |
| Dec 31, 2023 | 656,000.00 |
| Sep 30, 2023 | 612,000.00 |
| Jun 30, 2023 | 303,000.00 |
| Mar 31, 2023 | 275,000.00 |
| Dec 31, 2022 | 187,000.00 |
| Sep 30, 2022 | 145,000.00 |
| Jun 30, 2022 | 117,000.00 |
| Mar 31, 2022 | 98,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 35,000.00 |